GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Syra Health Corp (NAS:SYRA) » Definitions » YoY EBITDA Growth

Syra Health (Syra Health) YoY EBITDA Growth : -109.52% (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Syra Health YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Syra Health's YoY EBITDA Growth for the quarter that ended in Mar. 2024 was -109.52%.

Syra Health's EBITDA per Share for the three months ended in Mar. 2024 was $-0.22.

Syra Health YoY EBITDA Growth Historical Data

The historical data trend for Syra Health's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Syra Health YoY EBITDA Growth Chart

Syra Health Annual Data
Trend Dec20 Dec21 Dec22 Dec23
YoY EBITDA Growth
- - - -103.86

Syra Health Quarterly Data
Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only -45.83 -24.53 10.71 -88.89 -109.52

Syra Health YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Syra Health's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

YoY EBITDA Growth (A: Dec. 2023 )
=(EBITDA per Share (A: Dec. 2023 )-EBITDA per Share (A: Dec. 2022 ))/ | EBITDA per Share (A: Dec. 2022 ) |
=(-0.581--0.285)/ | -0.285 |
=-103.86 %

Syra Health's YoY EBITDA Growth for the quarter that ended in Mar. 2024 is calculated as:

YoY EBITDA Growth (Q: Mar. 2024 )
=(EBITDA per Share (Q: Mar. 2024 )-EBITDA per Share (Q: Mar. 2023 )) / | EBITDA per Share (Q: Mar. 2023 )) |
=(-0.22--0.105)/ | -0.105 |
=-109.52 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Syra Health YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Syra Health's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Syra Health (Syra Health) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Syra Health Corp (NAS:SYRA) » Definitions » YoY EBITDA Growth
Comparable Companies
JRSS RHE GBNH USNU BACK IONM GRST HLYK BNKL ARPC HCA SAU:4013 SZSE:300015 HKSE:06618 XTER:FRE BKK:BDMS XKLS:5225 BSP:RDOR3 XTER:FME UHS
Traded in Other Exchanges
N/A
Address
1119 Keystone Way North, No. 201, Carmel, IN, USA, 46032
Website
https://www.syrahealth.com
Syra Health Corp is a healthcare services company promoting preventative health, holistic wellness, health education, and equitable healthcare for all patient demographics. The company leverages deep scientific and healthcare expertise to create strategic frameworks and develop patient-centric solutions for the betterment of patient lives and health outcome linked to developing a healthier population. It strives to offer comprehensive end-to-end solutions in health education services, population health management, behavioral and mental health, healthcare workforce and digital health. The Company has two main forms of revenue - healthcare staffing revenue and medical communication revenue. The majority of revenue is derived from healthcare staffing.
Executives
Sandeep Allam director, officer: President and Chair 1119 KEYSTONE WAY N., #201, CARMEL IN 46032
Feroz Syed 10 percent owner 1119 KEYSTONE WAY N., #201, CARMEL IN 46032
Deepika Vuppalanchi director, officer: Chief Executive Officer 1119 KEYSTONE WAY N., #201, CARMEL IN 46032
Vijayapal Reddy director 1119 KEYSTONE WAY N., #201, CARMEL IN 46032
Avutu Reddy director 1119 KEYSTONE WAY N., #201, CARMEL IN 46032
Ketan Paranjape director 1119 KEYSTONE WAY N., #201, CARMEL IN 46032
Andrew Dahlem director 1119 KEYSTONE WAY N., #201, CARMEL IN 46032
Sherron Rogers director 1119 KEYSTONE WAY N., #201, CARMEL IN 46032
Joe D Thomas 10 percent owner 2046 EAST MURRAY-HOLIDAY ROAD, SALT LAKE CITY UT 84117
Sls Group Llc 10 percent owner 6582 S BIG COTTONWOOD CANYON RD. #200, SALT LAKE CITY UT 84121
Priya Prasad officer: CFO and COO 1119 KEYSTONE WAY N., #201, CARMEL IN 46032